Anja Krammer joined our board in June 2020. In early 2020, Ms. Krammer was appointed as chief executive officer of Turn Biotechnologies, a development-stage company focused on reversing aging and age-related diseases. From 2013 through 2018, she cofounded and served as president, secretary, and a director of BioPharmX, a specialty pharmaceutical company, where she led the initial public offering onto the New York Stock Exchange in 2015. Ms. Krammer served as principal/founder of MBI, Inc., a management consulting firm, beginning in January 1998. While at MBI, Inc., Ms. Krammer also served as vice president of global marketing from April 2006 to August 2008 for Reliant Technologies, a venture-backed startup in aesthetic medicine. From April 2004 to April 2006, Ms. Krammer served as senior director of strategic marketing for Medtronic Corporation. From December 2000 to September 2001, Ms. Krammer was vice president of solutions marketing for Getronics Corporation, a global IT services company. From April 1999 to December 2000, Ms. Krammer served as vice president of indirect channel sales and worldwide industry partnership marketing in the Itronix Division of Acterna Corporation, an optical communications company.
Ms. Krammer’s other prior roles include serving as director of worldwide marketing and communications for Tektronix Corporation in its color printing and imaging division from October 1997 to April 1999. From October 1995 to October 1997, Ms. Krammer was director of worldwide sales and marketing with KeyTronic Corporation, a computer equipment manufacturer.
Ms. Krammer holds a BAIS degree with a focus on marketing/management from the University of South Carolina and an international trade certificate from Paris-Sorbonne University.